logo
Plus   Neg
Share
Email

Roche: Port Delivery System With Ranibizumab Shows Positive Trial Results In NAMD

Swiss drug maker Roche (RHHBY) announced Wednesday positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab in people living with neovascular or "wet" age-related macular degeneration or nAMD.

Port Delivery System with ranibizumab or PDS is a permanent refillable eye implant, approximately the size of a grain of rice, which continuously delivers a customised formulation of ranibizumab over a period of months.

The company noted that the Archway trial met its primary endpoint, demonstrating that patients with PDS who received refills every six months achieved visual acuity outcomes equivalent to those receiving monthly ranibizumab 0.5 mg injections.

In Archway, PDS was generally well-tolerated with a favorable benefit-risk profile.

Levi Garraway, Roche's Chief Medical Officer and Head of Global Product Development, said, "For people around the world receiving frequent eye injections for neovascular AMD, this continuous delivery system could greatly reduce their treatment burden."

The company expects to present detailed Archway results at an upcoming medical meeting and to submit to regulatory authorities across the world.

The Portal study is also investigating the long-term safety and tolerability of PDS for the treatment of nAMD. PDS is also being studied in the Pagoda trial for the treatment of diabetic macular edema or DME, a vision-threatening complication of diabetes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford has revived the iconic Bronco brand after a gap of 24 years, this time as a dedicated off-road brand aiming to take on Fiat Chrysler's Jeep Wrangler, the dominant vehicle in the off-road category. Ford has introduced three new vehicles under the all-new Bronco brand as a 4x4 family of rugged SUVs under the tagline, "Built Wild". 3M Co. is teaming with researchers at Massachusetts Institute of Technology or MIT to develop a new rapid antigen test that detects the COVID-19 virus. The research, being conducted at the pilot lab facility at 3M's headquarters in St. Paul, Minnesota, is to learn if a simple-to-use, diagnostic device can produce highly accurate results within minutes and is feasible to mass manufacture. Retail giant Walmart has teamed up with the U.S. Department of Agriculture (USDA) to enable customers who pay for groceries with SNAP benefits, to gain access to Walmart's pickup and delivery service. Nearly 3,000 Walmart stores in 39 U.S. states are now offering customers receiving SNAP benefits through their Electronic Benefit Transfer (EBT) card to complete payments using the EBT card.
Follow RTT